Niya Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Niya Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $1.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Niya Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.7M Trade | TransData Nexus

Niya Healthcare Private Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $1.7M Total Trade · DGFT Verified

Niya Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.7M across 2 products in 2 therapeutic categories. Based on 83 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Phenylephrine ($1.5M), Secnidazole ($250.0K), .

Niya Healthcare Private Limited — Export Portfolio & Destination Treemap

Niya Healthcare Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Niya Healthcare Private Limited? — Company Overview & Market Position

Niya Healthcare Private Limited, established on April 12, 2006, is a private unlisted company headquartered in Satara, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U85100PN2006PTC022320. Its authorized and paid-up capital stands at ₹100,000 each. The registered office is located at Plot No.36 S No. 19B/20B, Tulasi Vihar Visawa Park, Godoli, Satara, Maharashtra, 415002.

Niya Healthcare specializes in the manufacturing and export of pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company has a significant presence in the global pharmaceutical market, with exports totaling $1.7 million USD across 83 shipments from 2022 to 2026. Its product portfolio is concentrated in two therapeutic categories: Respiratory & OTC (85.6%) and Advanced Antibiotics (14.4%). The top five products, including Phenylephrine and Secnidazole, account for 100% of the company's export value.

What Does Niya Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Phenylephrine$1.5M 2

Product Portfolio — Top 2 by Export Value

Niya Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Phenylephrine	Respiratory & OTC	$1.5M	78	1.7%	10
2	Secnidazole	Advanced Antibiotics	$250.0K	5	0.8%	8

Niya Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.7M. The top category is Respiratory & OTC (85.6% of portfolio), followed by Advanced Antibiotics (14.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Niya Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Niya Healthcare operates manufacturing facilities in Satara, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific details regarding plant capacities and certifications are not publicly disclosed, Niya Healthcare emphasizes its compliance with global regulatory standards, including EU GMP, WHO-GMP, USFDA, and ISO-9001. (nhpl.co)

3Key Leadership

The leadership team at Niya Healthcare Private Limited comprises:

Yatin Narayandas Doshi: Director
Mohini Narayandas Doshi: Director
Supriya Yatin Doshi: Director

All three directors have been with the company since its inception on April 12, 2006.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Niya Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Niya Healthcare Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has registered its products in various countries across Europe, Africa, Asia, Central and South America, and the Commonwealth of Independent States (CIS). Niya Healthcare's compliance with global regulatory agencies such as EU GMP, WHO-GMP, USFDA, and ISO-9001 underscores its commitment to meeting international standards. (nhpl.co)

2Emerging Markets

Niya Healthcare Private Limited has expanded its reach into emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification and EU GMP certifications facilitates access to these markets, enabling it to meet the regulatory requirements necessary for product registration and distribution. (nhpl.co)

3Geographic Strategy

Niya Healthcare's export strategy demonstrates a strong focus on the Respiratory & OTC therapeutic category, which constitutes 85.6% of its export value. This concentration indicates a strategic emphasis on a specific market segment. The company's expansion into diverse geographic regions, including regulated and emerging markets, reflects a deliberate approach to mitigate concentration risk and leverage growth opportunities across various global markets.

Niya Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Niya Healthcare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's compliance with global regulatory standards, including USFDA, suggests adherence to FDA requirements. (nhpl.co)

2WHO & EU GMP

Niya Healthcare Private Limited holds certifications from the World Health Organization's Good Manufacturing Practice (WHO-GMP) and the European Union's Good Manufacturing Practice (EU GMP). These certifications affirm the company's commitment to maintaining high-quality manufacturing standards and facilitate access to international markets that require such compliance. (nhpl.co)

3CDSCO & Indian Regulatory

Niya Healthcare Private Limited operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Additionally, Niya Healthcare has obtained export No Objection Certificates (NOCs), enabling it to export pharmaceutical products to various international markets. (nhpl.co)

Niya Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export sector, Niya Healthcare Private Limited faces competition from both domestic and international companies. While specific competitors in overlapping categories are not publicly disclosed, Niya Healthcare's focus on the Respiratory & OTC therapeutic category positions it in a competitive market segment. The company's compliance with global regulatory standards, including EU GMP, WHO-GMP, USFDA, and ISO-9001, provides a competitive edge in meeting international market requirements. (nhpl.co)

2Key Differentiators

Niya Healthcare's key differentiators include its specialized focus on the Respiratory & OTC therapeutic category, accounting for 85.6% of its export value. The company's adherence to global regulatory standards, such as EU GMP, WHO-GMP, USFDA, and ISO-9001, underscores its commitment to quality and compliance. Additionally, Niya Healthcare's strategic expansion into diverse geographic regions, including regulated and emerging markets, enhances its global presence and market reach. (nhpl.co)

3Strategic Position

Niya Healthcare Private Limited's current strategic direction focuses on the export of finished pharmaceutical formulations, with a particular emphasis on the Respiratory & OTC therapeutic category. The company's adherence to global regulatory standards and its expansion into diverse geographic regions reflect a strategy aimed at mitigating concentration risk and leveraging growth opportunities across various international markets. Looking ahead, Niya Healthcare is well-positioned to continue its growth trajectory by capitalizing on its strengths in quality manufacturing and regulatory compliance. (nhpl.co)

Buyer Due Diligence Brief — Evaluating Niya Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Niya Healthcare Private Limited has demonstrated a consistent track record in pharmaceutical exports, with a total export value of $1.7 million USD across 83 shipments from 2022 to 2026. The company's portfolio is concentrated in two therapeutic categories: Respiratory & OTC (85.6%) and Advanced Antibiotics (14.4%). The top five products, including Phenylephrine and Secnidazole, account for 100% of the company's export value. This concentration indicates a focused approach to product offerings. The company's adherence to global regulatory standards, such as EU GMP, WHO-GMP, USFDA, and ISO-9001, underscores its commitment to quality and compliance, enhancing its reliability as a supplier. (nhpl.co)

2Certifications to Verify

Importers should verify the following certifications when considering Niya Healthcare Private Limited as a supplier:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration (FDA) to ensure compliance with U.S. regulations.

WHO-GMP Certification: Verify the World Health Organization's Good Manufacturing Practice certification to ensure adherence to international manufacturing standards.

Frequently Asked Questions — Niya Healthcare Private Limited

How many pharmaceutical products does Niya Healthcare Private Limited export from India?

Niya Healthcare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Phenylephrine ($1.5M), Secnidazole ($250.0K). Total export value is $1.7M.

What is Niya Healthcare Private Limited's total pharmaceutical export value?

Niya Healthcare Private Limited's total pharmaceutical export value is $1.7M, based on 83 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Niya Healthcare Private Limited cover?

Niya Healthcare Private Limited exports across 2 therapeutic categories. The largest are Respiratory & OTC (85.6%, 1 products), Advanced Antibiotics (14.4%, 1 products).

Get Full Niya Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.